CIK: 1666236 - Address: 3100 Hanover Street, Palo Alto, CA 94304
21 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
10/2/24 16:37
9/30/24
DNLIDenali Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagKrognes Steve E.CADS-87129.030-30-3841D
8/22/24 16:15
8/20/24
DNLIDenali Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagKrognes Steve E.CADS-4123.790-20871D
7/3/24 21:13
6/13/24
DNLIDenali Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagKrognes Steve E.CADS.m-67922.110-31-3873D
4/2/24 18:07
4/1/24
DNLIDenali Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagKrognes Steve E.CADS-1,89620.500-93-9897D
2/15/24 21:16
2/13/24
DNLIDenali Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagKrognes Steve E.CADS-4817.290-30990D
1/9/24 19:34
1/5/24
DNLIDenali Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagKrognes Steve E.CADS-6219.430-30993D
8/23/23 16:31
8/21/23
DNLIDenali Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagKrognes Steve E.CADS-3222.600-10996D
2/15/23 19:02
2/13/23
DNLIDenali Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagKrognes Steve E.CADS-6430.100-20993D
2/10/23 18:10
2/8/23
DNLIDenali Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagKrognes Steve E.CADS-4330.880-10995D
1/9/23 21:42
1/5/23
DNLIDenali Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagKrognes Steve E.CADS-8428.440-30996D
8/23/22 16:47
8/19/22
DNLIDenali Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagKrognes Steve E.CADS-7533.220-20999D
2/15/22 18:56
2/11/22
DNLIDenali Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagKrognes Steve E.CAOCFO,TreaS-8934.690-30970D
2/11/22 17:20
2/9/22
DNLIDenali Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagKrognes Steve E.CAOCFO,TreaS-4837.090-10973D
1/7/22 18:06
1/5/22
DNLIDenali Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagKrognes Steve E.CAOCFO,TreaS-10044.750-20974D
8/23/21 20:24
8/19/21
DNLIDenali Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagKrognes Steve E.CAOCFO,TreaS-11349.570-20945D
3/16/21 19:16
3/15/21
DNLIDenali Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagKrognes Steve E.CAOCFO,TreaS-3,09561.890-50-5948I
2/18/21 18:12
2/16/21
DNLIDenali Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagKrognes Steve E.CAOCFO,TreaS-3,25565.090-50-5998I
2/16/21 19:42
2/11/21
DNLIDenali Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagKrognes Steve E.CAOCFO,TreaS-21370.340-301,048D
2/11/21 19:11
2/9/21
DNLIDenali Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagKrognes Steve E.CAOCFO,TreaS.d-10874.680-10963D
1/20/21 18:46
1/15/21
DNLIDenali Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagKrognes Steve E.CAOCFO,TreaS-3,57371.450-50-5960I
4/1/20 18:19
3/30/20
DNLIDenali Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagKrognes Steve E.CAOCFO,TreaS-2819.480-101,006D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact